Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos L., Bar-Or A., Cree B. A. C., Fox R. J., Giovannoni G., Gold R., ...More

The Lancet, vol.391, no.10127, pp.1263-1273, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 391 Issue: 10127
  • Publication Date: 2018
  • Doi Number: 10.1016/s0140-6736(18)30475-6
  • Journal Name: The Lancet
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1263-1273
  • Karadeniz Technical University Affiliated: Yes